Ovariectomy Induces a Shift in Fuel Availability and Metabolism in the Hippocampus of the Female Transgenic Model of Familial Alzheimer's

PLoS ONE

Volumn 8, Issue 3, 2013, Pages

  Ding, Fan ^a   Yao, Jia ^a   Zhao, Liqin ^a   Mao, Zisu ^a   Chen, Shuhua ^a   Brinton, Roberta Diaz ^a,b  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 DEOXY 2 FLUOROMANNOSE F 18; 3 OXOACID COENZYME A TRANSFERASE; BETA AMYLOID OLIGOMER; ESTRADIOL; GLUCOSE; GLUCOSE TRANSPORTER; HEXOKINASE; KETONE BODY; LACTATE DEHYDROGENASE; LACTATE DEHYDROGENASE 1; LACTATE DEHYDROGENASE 5; MONOCARBOXYLATE TRANSPORTER 2; OLIGOMER; UNCLASSIFIED DRUG;

AEROBIC GLYCOLYSIS; ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOENERGY; BLOOD BRAIN BARRIER; BRAIN METABOLISM; CONTROLLED STUDY; DISEASE MODEL; ENERGY METABOLISM; ENZYME ACTIVITY; ESTROGEN THERAPY; FAMILIAL DISEASE; GENE EXPRESSION; GLUCOSE BRAIN LEVEL; GLUCOSE METABOLISM; GLUCOSE TRANSPORT; GLYCOLYSIS; HIPPOCAMPUS; MOUSE; NONHUMAN; OVARIECTOMY; POSITRON EMISSION TOMOGRAPHY; PROTEIN EXPRESSION; SKIN TEMPERATURE; TAIL SKIN TEMPERATURE; TRANSGENIC MOUSE; WEIGHT GAIN;

ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; ANIMALS; BODY WEIGHT; BRAIN; DISEASE MODELS, ANIMAL; ESTRADIOL; ESTROGENS; FEMALE; GENE EXPRESSION REGULATION; GLUCOSE; GLYCOLYSIS; HIPPOCAMPUS; ISOENZYMES; L-LACTATE DEHYDROGENASE; LACTATES; MICE; MICE, TRANSGENIC; MITOCHONDRIA; NEURONS; OVARIECTOMY; OVARY; POSITRON-EMISSION TOMOGRAPHY; SKIN TEMPERATURE; X-RAY MICROTOMOGRAPHY;

MUS;

EID: 84875423210     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0059825     Document Type: Article

References (64)

1. Yao J, Irwin RW, Zhao L, Nilsen J, Hamilton RT, et al. (2009) Mitochondrial bioenergetic deficit precedes Alzheimer's pathology in female mouse model of Alzheimer's disease. Proceedings of the National Academy of Sciences of the United States of America 106: 14670-14675.
2. Yao J, Irwin R, Chen S, Hamilton R, Cadenas E, et al. (2011) Ovarian hormone loss induces bioenergetic deficits and mitochondrial beta-amyloid. Neurobiology of aging.
3. Mosconi L, (2005) Brain glucose metabolism in the early and specific diagnosis of Alzheimer's disease. FDG-PET studies in MCI and AD. European journal of nuclear medicine and molecular imaging 32: 486-510.
4. Mosconi L, Mistur R, Switalski R, Tsui WH, Glodzik L, et al. (2009) FDG-PET changes in brain glucose metabolism from normal cognition to pathologically verified Alzheimer's disease. European journal of nuclear medicine and molecular imaging 36: 811-822.
5. Mosconi L, Sorbi S, de Leon MJ, Li Y, Nacmias B, et al. (2006) Hypometabolism exceeds atrophy in presymptomatic early-onset familial Alzheimer's disease. Journal of nuclear medicine: official publication, Society of Nuclear Medicine 47: 1778-1786.
6. Reiman EM, Caselli RJ, Yun LS, Chen K, Bandy D, et al. (1996) Preclinical evidence of Alzheimer's disease in persons homozygous for the epsilon 4 allele for apolipoprotein E. The New England journal of medicine. 334: 752-758.
7. Reiman EM, Chen K, Alexander GE, Caselli RJ, Bandy D, et al. (2004) Functional brain abnormalities in young adults at genetic risk for late-onset Alzheimer's dementia. Proceedings of the National Academy of Sciences of the United States of America 101: 284-289.
8. Vaishnavi SN, Vlassenko AG, Rundle MM, Snyder AZ, Mintun MA, et al. (2010) Regional aerobic glycolysis in the human brain. Proceedings of the National Academy of Sciences of the United States of America 107: 17757-17762.
9. Vlassenko AG, Vaishnavi SN, Couture L, Sacco D, Shannon BJ, et al. (2010) Spatial correlation between brain aerobic glycolysis and amyloid-beta (Abeta) deposition. Proceedings of the National Academy of Sciences of the United States of America 107: 17763-17767.
10. Hoyer S, (1991) Abnormalities of glucose metabolism in Alzheimer's disease. Annals of the New York Academy of Sciences 640: 53-58.
11. Bishop J, Simpkins JW, (1995) Estradiol enhances brain glucose uptake in ovariectomized rats. Brain research bulletin 36: 315-320.
12. Kostanyan A, Nazaryan K, (1992) Rat brain glycolysis regulation by estradiol-17 beta. Biochimica et biophysica acta 1133: 301-306.
13. Nilsen J, Irwin RW, Gallaher TK, Brinton RD, (2007) Estradiol in vivo regulation of brain mitochondrial proteome. The Journal of neuroscience: the official journal of the Society for Neuroscience 27: 14069-14077.
14. Brinton RD, (2008) The healthy cell bias of estrogen action: mitochondrial bioenergetics and neurological implications. Trends in neurosciences 31: 529-537.
15. Nilsen J, Diaz Brinton R, (2003) Mechanism of estrogen-mediated neuroprotection: regulation of mitochondrial calcium and Bcl-2 expression. Proceedings of the National Academy of Sciences of the United States of America 100: 2842-2847.
16. Maki PM, Resnick SM, (2001) Effects of estrogen on patterns of brain activity at rest and during cognitive activity: a review of neuroimaging studies. NeuroImage 14: 789-801.
17. Rasgon NL, Silverman D, Siddarth P, Miller K, Ercoli LM, et al. (2005) Estrogen use and brain metabolic change in postmenopausal women. Neurobiology of aging 26: 229-235.
18. Eberling JL, Reed BR, Coleman JE, Jagust WJ, (2000) Effect of estrogen on cerebral glucose metabolism in postmenopausal women. Neurology 55: 875-877.
19. Yao J, Hamilton RT, Cadenas E, Brinton RD, (2010) Decline in mitochondrial bioenergetics and shift to ketogenic profile in brain during reproductive senescence. Biochimica et biophysica acta 1800: 1121-1126.
20. Oddo S, Caccamo A, Shepherd JD, Murphy MP, Golde TE, et al. (2003) Triple-transgenic model of Alzheimer's disease with plaques and tangles: intracellular Abeta and synaptic dysfunction. Neuron 39: 409-421.
21. Zhao L, Morgan TE, Mao Z, Lin S, Cadenas E, et al. (2012) Continuous versus cyclic progesterone exposure differentially regulates hippocampal gene expression and functional profiles. PloS one 7: e31267.
22. Deecher DC, Dorries K, (2007) Understanding the pathophysiology of vasomotor symptoms (hot flushes and night sweats) that occur in perimenopause, menopause, and postmenopause life stages. Archives of women's mental health 10: 247-257.
23. Williams H, Dacks PA, Rance NE, (2010) An improved method for recording tail skin temperature in the rat reveals changes during the estrous cycle and effects of ovarian steroids. Endocrinology 151: 5389-5394.
24. Vannucci SJ, Clark RR, Koehler-Stec E, Li K, Smith CB, et al. (1998) Glucose transporter expression in brain: relationship to cerebral glucose utilization. Developmental neuroscience 20: 369-379.
25. Pauwels EK, Sturm EJ, Bombardieri E, Cleton FJ, Stokkel MP, (2000) Positron-emission tomography with [18F]fluorodeoxyglucose. Part I. Biochemical uptake mechanism and its implication for clinical studies. Journal of cancer research and clinical oncology 126: 549-559.
26. Wilson JE, (1995) Hexokinases. Reviews of physiology, biochemistry and pharmacology 126: 65-198.
27. Sharma V, Luker GD, Piwnica-Worms D, (2002) Molecular imaging of gene expression and protein function in vivo with PET and SPECT. Journal of magnetic resonance imaging: JMRI 16: 336-351.
28. Pellerin L, (2003) Lactate as a pivotal element in neuron-glia metabolic cooperation. Neurochemistry international 43: 331-338.
29. Pellerin L, Pellegri G, Martin JL, Magistretti PJ, (1998) Expression of monocarboxylate transporter mRNAs in mouse brain: support for a distinct role of lactate as an energy substrate for the neonatal vs. adult brain. Proceedings of the National Academy of Sciences of the United States of America 95: 3990-3995.
30. Belanger M, Allaman I, Magistretti PJ, (2011) Brain energy metabolism: focus on astrocyte-neuron metabolic cooperation. Cell metabolism 14: 724-738.
31. Yao J, Rettberg JR, Klosinski LP, Cadenas E, Brinton RD, (2011) Shift in brain metabolism in late onset Alzheimer's disease: implications for biomarkers and therapeutic interventions. Molecular aspects of medicine 32: 247-257.
32. Venkov L, Rosental L, Manolova M, (1976) Subcellular distribution of LDH isoenzymes in neuronal- and glial-enriched fractions. Brain research 109: 323-333.
33. Laughton JD, Bittar P, Charnay Y, Pellerin L, Kovari E, et al. (2007) Metabolic compartmentalization in the human cortex and hippocampus: evidence for a cell- and region-specific localization of lactate dehydrogenase 5 and pyruvate dehydrogenase. BMC neuroscience 8: 35.
34. Ross JM, Oberg J, Brene S, Coppotelli G, Terzioglu M, et al. (2010) High brain lactate is a hallmark of aging and caused by a shift in the lactate dehydrogenase A/B ratio. Proceedings of the National Academy of Sciences of the United States of America 107: 20087-20092.
35. Yesavage JA, Holman CA, Berger PA, (1982) Cerebrospinal fluid lactate levels and aging: findings in normals and patients with major depressive disorders. Gerontology 28: 377-380.
36. Bentourkia M, Tremblay S, Pifferi F, Rousseau J, Lecomte R, et al. (2009) PET study of 11C-acetoacetate kinetics in rat brain during dietary treatments affecting ketosis. American journal of physiology Endocrinology and metabolism 296: E796-801.
37. Lazic SE (2011) Modeling hippocampal neurogenesis across the lifespan in seven species. Neurobiology of aging.
38. Klepper J, (2004) Impaired glucose transport into the brain: the expanding spectrum of glucose transporter type 1 deficiency syndrome. Current opinion in neurology 17: 193-196.
39. Gallicchio L, Whiteman MK, Tomic D, Miller KP, Langenberg P, et al. (2006) Type of menopause, patterns of hormone therapy use, and hot flashes. Fertility and sterility 85: 1432-1440.
40. Haney AF, Wild RA, (2007) Options for hormone therapy in women who have had a hysterectomy. Menopause 14: 592-597 quiz 598-599.
41. Mosconi L, Brys M, Switalski R, Mistur R, Glodzik L, et al. (2007) Maternal family history of Alzheimer's disease predisposes to reduced brain glucose metabolism. Proceedings of the National Academy of Sciences of the United States of America 104: 19067-19072.
42. Silverman DH, Mosconi L, Ercoli L, Chen W, Small GW, (2008) Positron emission tomography scans obtained for the evaluation of cognitive dysfunction. Seminars in nuclear medicine 38: 251-261.
43. Chen K, Langbaum JB, Fleisher AS, Ayutyanont N, Reschke C, et al. (2010) Twelve-month metabolic declines in probable Alzheimer's disease and amnestic mild cognitive impairment assessed using an empirically pre-defined statistical region-of-interest: findings from the Alzheimer's Disease Neuroimaging Initiative. NeuroImage 51: 654-664.
44. Edland SD, Silverman JM, Peskind ER, Tsuang D, Wijsman E, et al. (1996) Increased risk of dementia in mothers of Alzheimer's disease cases: evidence for maternal inheritance. Neurology 47: 254-256.
45. Mosconi L, Mistur R, Switalski R, Brys M, Glodzik L, et al. (2009) Declining brain glucose metabolism in normal individuals with a maternal history of Alzheimer disease. Neurology 72: 513-520.
46. Leybaert L, (2005) Neurobarrier coupling in the brain: a partner of neurovascular and neurometabolic coupling? Journal of cerebral blood flow and metabolism: official journal of the International Society of Cerebral Blood Flow and Metabolism 25: 2-16.
47. Barros LF, Porras OH, Bittner CX, (2005) Why glucose transport in the brain matters for PET. Trends in neurosciences 28: 117-119.
48. Kalaria RN, Harik SI, (1989) Reduced glucose transporter at the blood-brain barrier and in cerebral cortex in Alzheimer disease. Journal of neurochemistry 53: 1083-1088.
49. Pascual JM, Van Heertum RL, Wang D, Engelstad K, De Vivo DC, (2002) Imaging the metabolic footprint of Glut1 deficiency on the brain. Annals of neurology 52: 458-464.
50. De Vivo DC, Trifiletti RR, Jacobson RI, Ronen GM, Behmand RA, et al. (1991) Defective glucose transport across the blood-brain barrier as a cause of persistent hypoglycorrhachia, seizures, and developmental delay. The New England journal of medicine 325: 703-709.
51. Simpson IA, Chundu KR, Davies-Hill T, Honer WG, Davies P, (1994) Decreased concentrations of GLUT1 and GLUT3 glucose transporters in the brains of patients with Alzheimer's disease. Annals of neurology 35: 546-551.
52. Azoulay-Zohar H, Israelson A, Abu-Hamad S, Shoshan-Barmatz V, (2004) In self-defence: hexokinase promotes voltage-dependent anion channel closure and prevents mitochondria-mediated apoptotic cell death. The Biochemical journal 377: 347-355.
53. Gimenez-Cassina A, Lim F, Cerrato T, Palomo GM, Diaz-Nido J, (2009) Mitochondrial hexokinase II promotes neuronal survival and acts downstream of glycogen synthase kinase-3. The Journal of biological chemistry 284: 3001-3011.
54. Vyssokikh MY, Brdiczka D, (2003) The function of complexes between the outer mitochondrial membrane pore (VDAC) and the adenine nucleotide translocase in regulation of energy metabolism and apoptosis. Acta biochimica Polonica 50: 389-404.
55. Antuono PG, Ravanelli-Meyer J, Nicholson K, Bloom AS, (1995) Leukocyte hexokinase activity in aging and Alzheimer disease. Dementia 6: 200-204.
56. Marcus DL, Freedman ML, (1997) Decreased brain glucose metabolism in microvessels from patients with Alzheimer's disease. Annals of the New York Academy of Sciences 826: 248-253.
57. Sorbi S, Mortilla M, Piacentini S, Tonini S, Amaducci L, (1990) Altered hexokinase activity in skin cultured fibroblasts and leukocytes from Alzheimer's disease patients. Neuroscience letters 117: 165-168.
58. Suzuki A, Stern SA, Bozdagi O, Huntley GW, Walker RH, et al. (2011) Astrocyte-neuron lactate transport is required for long-term memory formation. Cell 144: 810-823.
59. Aubert A, Costalat R, Magistretti PJ, Pellerin L, (2005) Brain lactate kinetics: Modeling evidence for neuronal lactate uptake upon activation. Proceedings of the National Academy of Sciences of the United States of America 102: 16448-16453.
60. Klein WL, Stine WB Jr, Teplow DB, (2004) Small assemblies of unmodified amyloid beta-protein are the proximate neurotoxin in Alzheimer's disease. Neurobiology of aging 25: 569-580.
61. Klyubin I, Walsh DM, Lemere CA, Cullen WK, Shankar GM, et al. (2005) Amyloid beta protein immunotherapy neutralizes Abeta oligomers that disrupt synaptic plasticity in vivo. Nat Med 11: 556-561.
62. Lesne S, Koh MT, Kotilinek L, Kayed R, Glabe CG, et al. (2006) A specific amyloid-beta protein assembly in the brain impairs memory. Nature 440: 352-357.
63. Pavlides S, Tsirigos A, Vera I, Flomenberg N, Frank PG, et al. (2010) Transcriptional evidence for the "Reverse Warburg Effect" in human breast cancer tumor stroma and metastasis: similarities with oxidative stress, inflammation, Alzheimer's disease, and "Neuron-Glia Metabolic Coupling". Aging (Albany NY) 2: 185-199.
64. Rosario ER, Carroll JC, Pike CJ (2012) Evaluation of the effects of testosterone and luteinizing hormone on regulation of beta-amyloid in male 3×Tg-AD mice. Brain research.